Developing a pipeline of oncology products, including two clinical stage compounds originated by Niiki Pharma which target pathways in the endoplasmic reticulum in cancer cells.
Active Portfolio Company
www.intezyne.com
Location: United States, Florida, Tampa
Total raised: $10M
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.10.2017 | Series A | $10M | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| 07.10.2017 | Intezyne Closes Oversubscribed $10M Series A Financing | Intezyne Technologies, a clinical-stage biopharmaceutical company developing novel anti-cancer thera... | citybizlis... |